Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DD9VR3
|
|||
| Drug Name |
MIJ821
|
|||
| Synonyms |
CAD 9271
Click to Show/Hide
|
|||
| Indication | Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2; ICD-9: 296.2, 296.3] | Phase 2 | [1] | |
| Company |
Novartis; Cadent Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04722666) Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Cadent Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.